4Schmidt N,Ferger B. Neurochemical findings in the MPTP model of Parkinson's disease[J].J Neural Transm, 2001,108:1263- 1282.
5Ohashi S, Mori A, Kurihara N, Mitsumoto Y, Nakai M. Age related severity of dopaminergic neurodegeneration to MPTP neurotoxieity causes motor dysfunction in C57BL/6 mice[J]. Neurosci Lett,2006,401 : 183-187.
6Melrose H L, Lincoln S J, Tyndall G M, Farrer M J. Parkinson's disease : a rethink of rodent models [J]. Exp Brain Res,2006,173:196 -204.
7Carvey P M, Punati A, Newman M B. Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis[J]. Cell Transplant, 2006,15: 239-250.
8Bove J ,Zhou C,Jackson-lewis V,Taylor J,Chu Y,Rideout H J, et al. Proteasome inhibition and Parkinson' s disease modeling [J]. Ann Neurol, 2006,60 : 260-264.
9Collier T J, Lipton J, Daley B F, Palfi S, Chu Y, Sortwell C, et al. Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman promates: diminished compensatory mechanisms as a prelude to parkinsonism[J]. Neurobiol Dis, 2007,26 : 56-65.
10Miyamoto M. Characteristics of behavioral disorders in senescence-accelerated mouse (SAMPS) : possible animal model for dementia[J]. Nihon Shinkei Seishin Yakurigaku Zasshi, 1994, 14 : 323-335.
